# Prior culture-guided prediction of antibiotic susceptibility in recurrent respiratory tract infections: a retrospective cohort analysis

**Authors:** Shiyu Li, Wenxia Zhang, Hanwen Ma, Xiang Gao, Weian Yuan, Min He

PMC · DOI: 10.3389/fcimb.2025.1715986 · Frontiers in Cellular and Infection Microbiology · 2026-01-06

## TL;DR

This study shows that prior culture results can effectively predict antibiotic resistance in recurrent respiratory infections, helping choose better empirical treatments.

## Contribution

The study introduces a Bayesian method to quantify the predictive value of prior cultures for antibiotic susceptibility in recurrent respiratory tract infections.

## Key findings

- Prior cultures predicted future resistance to 22 antibiotics with >70% accuracy.
- Ciprofloxacin and levofloxacin showed ≥85% predictive value for resistance.
- Imipenem and amikacin had ≥85% predictive value for future susceptibility.

## Abstract

Recurrent respiratory tract infections (RRTIs) are a serious problem in older adults, necessitating appropriate early empiric antibiotic therapy. However, rising antimicrobial resistance complicates empiric treatment selection. Although prior culture results can offer guidance for empiric decisions, little data exist to quantify their predictive value in RRTIs. Therefore, we constructed a respiratory antibiogram and assessed Bayesian metrics of prior gram-negative isolates for predicting subsequent resistance or susceptibility in this population.

A retrospective cohort included hospitalized RRTI patients (defined as RTIs occurring ≥2 times in 6 months or ≥3 times in 12 months). Patient-specific antibiograms were constructed. A Bayesian prevalence-calibrated estimation was used to assess the predictive validity of prior respiratory cultures for subsequent antimicrobial susceptibility in paired isolates. Sensitivity (Sen), specificity (Spec), Bayesian positive predictive value (PPV), negative predictive value (NPV), and resistance prevalence were calculated for 24 antibiotics, with bootstrap 95% confidence intervals. Analyses were restricted to bacterial pathogens.

We included 463 visits from 160 unique patients, with a median age of 70. Pathogen distribution revealed Gram-negative bacteria (89.50%) and Gram-positive bacteria (10.50%). Antibiogram results showed that Pseudomonas aeruginosa exhibited >30% resistance to 10 antibiotics, while Klebsiella pneumoniae exhibited >35% resistance to 16 antibiotics. Prior cultures had good predictive value (>70%) for detecting future resistance to 22 antibiotics, with ciprofloxacin, levofloxacin, cefuroxime, cefotaxime, ampicillin, ampicillin/sulbactam, and ceftriaxone showing excellent predictive values (≥85%). Additionally, prior cultures had excellent predictive value (≥85%) for detecting future susceptibility to imipenem, amikacin, tobramycin, meropenem, minocycline, and tigecycline.

Considerable antibiotic resistance was detected among isolates in patients with RRTIs. Using a prior culture as a guide can enhance the probability of selecting an effective empirical agent.

## Linked entities

- **Chemicals:** ciprofloxacin (PubChem CID 2764), levofloxacin (PubChem CID 149096), cefuroxime (PubChem CID 5479529), cefotaxime (PubChem CID 5742673), ampicillin (PubChem CID 6249), ampicillin/sulbactam (PubChem CID 119561), ceftriaxone (PubChem CID 5479530), imipenem (PubChem CID 104838), amikacin (PubChem CID 37768), tobramycin (PubChem CID 36294), meropenem (PubChem CID 441130), minocycline (PubChem CID 54675783), tigecycline (PubChem CID 54686904)
- **Species:** Pseudomonas aeruginosa (taxon 287), Klebsiella pneumoniae (taxon 573)

## Full-text entities

- **Diseases:** RRTIs (MESH:D012141)
- **Chemicals:** meropenem (MESH:D000077731), cefotaxime (MESH:D002439), ceftriaxone (MESH:D002443), ampicillin (MESH:D000667), tigecycline (MESH:D000078304), imipenem (MESH:D015378), ampicillin/sulbactam (MESH:C035444), minocycline (MESH:D008911), ciprofloxacin (MESH:D002939), tobramycin (MESH:D014031), amikacin (MESH:D000583), cefuroxime (MESH:D002444), levofloxacin (MESH:D064704)
- **Species:** Klebsiella pneumoniae (species) [taxon 573], Homo sapiens (human, species) [taxon 9606], Pseudomonas aeruginosa (species) [taxon 287]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12816384/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12816384/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12816384/full.md

---
Source: https://tomesphere.com/paper/PMC12816384